HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

The Dutch OTC Market In 2018: Pharmacists Not Consumer Friendly, Supermarkets Capitalize

Executive Summary

While the Dutch OTC market grew steadily by 3.2% to €753m in 2018, according to IQVIA data, the country's self-care industry association, Neprofarm, pointed to a changing retail landscape in the Netherlands where supermarkets are grabbing market share from pharmacies. 

You may also be interested in...



Dutch OTC Market in 2019: VMS Delisting Accelerates Shift Towards Self-Care

A delisting of vitamin D and calcium food supplements accelerates a long-term shift towards self-care among Dutch consumers, according to the latest market data from local industry association, Neprofarm, in collaboration with IQVIA. 

Romania’s OTC Market in 2018: Colds And Flu Epidemic Help Boost Sales By 14%

Romanian self-care industry association, RASCI, provides HBW Insight with an exclusive viewpoint on the country's OTC market in 2018. 

Germany’s OTC Market in 2018: Online Sees Double-Digit Growth, Bionorica’s Canephron Uno Tops New Launches

Germany's online channel continued to expand to expand in 2018, with OTC product sales via mail-order pharmacy growing almost 10-times faster than through bricks-and-mortar pharmacy. Meanwhile, GSK's Voltaren brand was top-seller through both channels and Bionorica's Canephron Uno was the best-selling launch during the 12 months. 

Topics

UsernamePublicRestriction

Register

LL1134044

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel